2026 NPPES data Otolaryngology Physician NPI 1720290083 M.D., PH.D.
Verify on CMS →

RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.

Otolaryngology Physician in MAYAGUEZ, Puerto Rico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 537 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
99%
generic claims · 1% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. filed 2,944 Medicare Part D claims in 2023 as a Otolaryngology Physician in MAYAGUEZ, Puerto Rico, prescribing 99% generic.

3K
Part D claims, 2023
99%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,944 Top 12% higher than 88% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.?

Quality data not reported

NPI registry status

Active

Issued 05/07/2007

NPI 1720290083

Primary specialty

Otolaryngology Physician

Mid-sized

10,895 US NPIs in this specialty

Medicare Part D claims

2,944 478% vs specialty avg

2023 prescription claims

Specialty avg: 509

Specialty distribution in Puerto Rico

How Otolaryngology Physician compares to other specialties among Puerto Rico providers

Puerto Rico providers

Otolaryngology Physician share within Puerto Rico

1. Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology Physician share within Puerto Rico

Specialty board-certification context

Estimated specialty board-certified rate — Otolaryngology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Otolaryngology Physician ABMS/AOA estimate

Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. is a Otolaryngology Physician provider practicing in MAYAGUEZ, Puerto Rico, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D., PH.D.. NPI: 1720290083. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. appears in the CMS NPPES registry as a Otolaryngology Physician provider holding M.D., PH.D. credentials at CARR 349 KM 2.7, MAYAGUEZ, PR, 00680, with a listed phone of (787) 832-4773. NPI 1720290083 was issued on 05/07/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what VELAZQUEZ-ROUSSET most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,944 prescription claims written by this provider, covering 537 Medicare beneficiaries and totaling roughly $53K in drug spend, split 1% brand-name and 99% generic by claim count, with an opioid prescribing rate of 1.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

CARR 349 KM 2.7
MAYAGUEZ, PR 00680

Provider Details

NPI 1720290083
Specialty Otolaryngology Physician
Credentials M.D., PH.D.
Gender Male
NPI Issued 05/07/2007

Hospital and facility affiliations

Facilities where RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BELLA VISTA HOSPITAL INC
MAYAGUEZ, PR

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Generic-heavy

RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. — brand share 1.0%
Specialty average (est.)

1% brand-name claims vs 99% generic, on 2,944 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,944
Total Claims
$53K
Total Drug Cost
537
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,222
Total Day Supply
90,974
Brand vs Generic
1% brand / 99% generic
Brand Drug Cost
$5K
Generic Drug Cost
$48K
Opioid Claims
53 (1.8% rate)
Antibiotic Claims
89

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
1.90
Gender Split
59% female / 41% male
Age Distribution
<65: 81, 65-74: 231, 75-84: 184, 85+: 41

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Fluticasone Propionate
1,011
Montelukast Sodium
645
Levocetirizine Dihydrochloride
497
Famotidine
138
Omeprazole
76
Azelastine-Fluticasone
Azelastine/Fluticasone
66
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
63
Fluocinolone Acetonide Oil
62
Azelastine Hcl
58
Pantoprazole Sodium
51

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology Physician Overview

How RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. fits within the Otolaryngology Physician landscape nationally.

10,895
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider

RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.'s 2,944 claims are above the specialty average of 509.

Nearby Otolaryngology Physician Providers in Puerto Rico

Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as VELAZQUEZ-ROUSSET.

Compare Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.'s specialty?
RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. specializes in Otolaryngology Physician and practices in MAYAGUEZ, Puerto Rico. Credentials: M.D., PH.D..
How much does RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. prescribe under Medicare Part D?
In 2023, RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. wrote 2,944 Medicare Part D claims totaling $53K in drug costs for 537 beneficiaries.
Where is RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. located?
RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. is located at CARR 349 KM 2.7, MAYAGUEZ, PR, 00680. Phone: (787) 832-4773.
What is RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.'s NPI number?
RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.'s National Provider Identifier (NPI) is 1720290083, issued on 05/07/2007.
Does RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. prescribe more brand-name or generic drugs?
RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.'s prescribing is 1% brand-name and 99% generic drugs by claim count, with $5K in brand drug costs.
Does RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. prescribe opioids?
Yes, RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. had 53 opioid claims in 2023 with an opioid prescribing rate of 1.8%.
How many Otolaryngology Physician providers are there in the US?
There are 10,895 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.'s most frequently prescribed drugs include Fluticasone Propionate, Montelukast Sodium, Levocetirizine Dihydrochloride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. accept Medicare?
RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D. appears in CMS Medicare data with 2,944 Part D claims and 537 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.'s credentials?
RUBEN VELAZQUEZ-ROUSSET, M.D., PH.D.'s NPI is 1720290083 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology